Search for Clinical Trial Results

Adrenocortical Carcinoma - 9 Studies Found

Status Study
Completed Study Name: Trial With Taxotere and Cisplatin in Non-operable Adrenocortical Carcinoma
Condition: Adrenocortical Carcinoma
Date: 2006-05-08
Interventions: Drug: cisplatin, taxotere cisplatin 75 mg/m2 Taxotere 75 mg/m2
Terminated Study Name: S9427, Suramin in Treating Patients With Stage III or Stage IV Adrenocortical Cancer Incurable by Surgery
Condition: Adrenocortical Carcinoma
Date: 1999-11-01
Interventions:
  • Drug: suramin
  • Drug: therapeutic hydrocorti
Active, not recruiting Study Name: Preclinical Study Towards an Immunotherapy in Adrenocortical Carcinoma
Condition:
  • Adrenocortical Carcinoma
  • Cushing's Syndrome

Date: 2007-04-04
Completed Study Name: A Study of Combination Chemotherapy and Surgical Resection in the Treatment of Adrenocortical Carcinoma: Continuous Infusion Doxorubicin, Vincristine and Etoposide With Daily Mitotane Before and After Surgical Resection
Condition: Adrenal Cortical Carcinoma
Date: 1999-11-03
Interventions: Drug: doxorubicin, vincristine, and etoposide with mitotane
Completed Study Name: A Study of the Safety and Effects of ADH-1 Given Intravenously as a Single Agent
Condition: Neoplasms
Date: 2005-12-12
Interventions: Drug: ADH -1 (Exherin™)
Completed Study Name: Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)
Condition: Solid Tumors
Date: 2013-01-14
Interventions: Drug: Avelumab Avelumab will be administered in study location using a protocol-defined dose escalation
Completed Study Name: Study of Radiotherapy and Pembrolizumab in People With Adrenocortical Carcinoma
Condition: Adrenocortical Carcinoma
Date: 2026-05-11
Interventions: All participants will first undergo ablative RT
Completed Study Name: Phase 1 Study of 68Ga-R8760
Condition: Adrenocortical Carcinoma
Date: 2026-05-11
Interventions: PET/CT imaging at predefined timepoints
Completed Study Name: A Phase II Study to Evaluate the Efficacy and Safety of Pembrolizumab in Combination With Mitotane in Patients With Advanced Adrenocortical Carcinoma
Condition: Adrenocortical Carcinoma
Date: 2026-05-11
Interventions: Given by PO